Have your own idea? Try our Stock Screener
U.S. Biotech Industry Analysis
UpdatedMay 29, 2025
DataAggregated Company Financials
Companies567
- 7D0.4%
- 3M-8.4%
- 1Y-9.6%
- YTD-5.4%
Over the last 7 days, the Biotech industry has dropped 1.0%, driven by Regeneron Pharmaceuticals declining 2.1%. The industry has fallen 10% in the last year. Looking forward, earnings are forecast to grow by 24% annually.
Industry Valuation and Performance
Has the U.S. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 29 May 2025 | US$918.0b | US$155.9b | -US$24,119,232,490.98 | 15.9x | -38.1x | 5.9x |
| Sat, 26 Apr 2025 | US$795.8b | US$119.2b | -US$31,094,794,492.82 | 20.1x | -25.6x | 6.7x |
| Mon, 24 Mar 2025 | US$827.4b | US$118.6b | -US$36,836,383,348.69 | 20.4x | -22.5x | 7x |
| Wed, 19 Feb 2025 | US$842.4b | US$116.6b | -US$36,830,915,932.52 | 17.4x | -22.9x | 7.2x |
| Fri, 17 Jan 2025 | US$951.1b | US$149.4b | -US$26,288,384,920.31 | 17.4x | -36.2x | 6.4x |
| Sun, 15 Dec 2024 | US$991.8b | US$150.0b | -US$26,493,336,471.94 | 16.6x | -37.4x | 6.6x |
| Tue, 12 Nov 2024 | US$1.1t | US$149.6b | -US$27,256,722,122.39 | 16.2x | -40.7x | 7.4x |
| Thu, 10 Oct 2024 | US$885.2b | US$113.1b | -US$35,888,682,575.95 | 19.9x | -24.7x | 7.8x |
| Sat, 07 Sep 2024 | US$873.8b | US$113.1b | -US$35,668,533,175.32 | 22.2x | -24.5x | 7.7x |
| Mon, 05 Aug 2024 | US$1.2t | US$165.8b | -US$32,343,076,510.84 | 25.9x | -37x | 7.2x |
| Wed, 03 Jul 2024 | US$1.1t | US$164.4b | -US$27,942,623,021.72 | 28.6x | -41.1x | 7x |
| Fri, 31 May 2024 | US$1.1t | US$164.6b | -US$26,676,846,840.12 | 27.1x | -41.7x | 6.8x |
| Sun, 28 Apr 2024 | US$1.1t | US$164.6b | -US$27,372,800,636.09 | 22.6x | -39.1x | 6.5x |
| Tue, 26 Mar 2024 | US$1.2t | US$164.3b | -US$23,900,589,317.23 | 21.6x | -48.6x | 7.1x |
| Thu, 22 Feb 2024 | US$1.2t | US$168.4b | -US$20,682,314,391.88 | 13.8x | -55.7x | 6.8x |
| Sat, 20 Jan 2024 | US$1.4t | US$204.8b | -US$22,506,538,466.00 | 18.5x | -63.3x | 7x |
| Mon, 18 Dec 2023 | US$1.4t | US$204.7b | -US$22,123,285,336.00 | 19.2x | -61x | 6.6x |
| Wed, 15 Nov 2023 | US$1.2t | US$204.7b | -US$22,084,019,583.00 | 18.8x | -54.5x | 5.9x |
| Fri, 13 Oct 2023 | US$1.3t | US$207.3b | -US$13,087,317,004.00 | 16.7x | -97.1x | 6.1x |
| Sun, 10 Sep 2023 | US$1.3t | US$207.5b | -US$12,633,744,533.00 | 17.4x | -101x | 6.1x |
| Tue, 08 Aug 2023 | US$1.3t | US$206.8b | -US$12,334,291,943.00 | 15.3x | -101.9x | 6.1x |
| Thu, 06 Jul 2023 | US$1.1t | US$186.2b | -US$16,071,351,382.00 | 13.4x | -70.3x | 6.1x |
| Sat, 03 Jun 2023 | US$1.1t | US$185.9b | -US$16,006,497,567.00 | 11.4x | -71.1x | 6.1x |
| Mon, 01 May 2023 | US$1.2t | US$197.1b | -US$6,664,428,484.00 | 13.7x | -173.7x | 5.9x |
| Wed, 29 Mar 2023 | US$1.1t | US$198.3b | -US$4,264,607,086.00 | 13.9x | -265.9x | 5.7x |
| Fri, 24 Feb 2023 | US$1.1t | US$200.7b | -US$3,634,575,903.00 | 15.6x | -312.9x | 5.7x |
| Sun, 22 Jan 2023 | US$1.2t | US$203.8b | US$1.8b | 14.4x | 655.3x | 5.7x |
| Tue, 20 Dec 2022 | US$1.1t | US$203.3b | US$1.6b | 14.3x | 701.1x | 5.6x |
| Thu, 17 Nov 2022 | US$1.1t | US$202.3b | US$1.3b | 14.6x | 874.8x | 5.5x |
| Sat, 15 Oct 2022 | US$1.0t | US$206.0b | US$5.4b | 15.6x | 194.6x | 5.1x |
| Mon, 12 Sep 2022 | US$1.1t | US$206.7b | US$5.8b | 15.6x | 188.1x | 5.3x |
| Wed, 10 Aug 2022 | US$1.1t | US$208.2b | US$5.6b | 16.2x | 196.7x | 5.3x |
| Fri, 08 Jul 2022 | US$1.1t | US$211.5b | US$10.8b | 17.4x | 101.4x | 5.2x |
| Sun, 05 Jun 2022 | US$1.0t | US$212.8b | US$11.3b | 16.4x | 88.7x | 4.7x |
Price to Earnings Ratio
88.7x
Current Industry PE
- Investors are relatively neutral on the American Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 6.3x.
Past Earnings Growth
- Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 9.8% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the U.S. Healthcare industry?
| US Market | 0.79% | |
| Healthcare | -0.19% | |
| Biotech | 0.44% | |
| Biotech | 0.44% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AMGN Amgen | US$278.40 | 2.6% +US$3.8b | -6.1% | PE25.2x | |
| VRTX Vertex Pharmaceuticals | US$445.10 | 2.2% +US$2.5b | 0.9% | PS10.3x | |
| ABBV AbbVie | US$183.09 | 0.7% +US$2.3b | 18.3% | PE77.8x | |
| NTRA Natera | US$161.21 | 6.7% +US$1.4b | 46.8% | PS12x | |
| GILD Gilead Sciences | US$108.44 | 0.7% +US$895.6m | 70.8% | PE22.6x |
